Molecular basis of γδ T lineage specification
γδ T 谱系规范的分子基础
基本信息
- 批准号:9793218
- 负责人:
- 金额:$ 214.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAffectArchitectureBindingBinding ProteinsBinding SitesCaliforniaCellsChromatin LoopChromosomesComplexDNADNA-Binding ProteinsDevelopmentDiseaseE proteinEventExhibitsFamilyFamily memberFox Chase Cancer CenterFundingGene ExpressionGenerationsGenetic TranscriptionGenomicsHealthHost DefenseHumanImmune responseIn VitroInterleukin-17KnowledgeLinkMediatingModelingMolecularMusPathologicPlayPluripotent Stem CellsPrincipal InvestigatorProductionPublic HealthReceptor SignalingRegulationRegulatory ElementRepressionResourcesRoleSignal TransductionSpecific qualifier valueSpecificityStem cellsStereotypingStudy modelsSystemSystems DevelopmentT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTCF3 geneTestingTherapeuticTimeTranscriptUniversitiesUntranslated RNAbasegenome-widehelix-loop-helix protein differentiation inhibitorhuman pluripotent stem cellimaging approachimmunopathologyinsightmembernovelpathogenprofessorprogenitorprogramsresponseskillstumorγδ T cells
项目摘要
PROJECT SUMMARY/ABSTRACT
Despite the growing appreciation for the critical role played by γδ T cells in host defense and immunopathology,
the molecular events controlling their development and effector function remain poorly understood. Our program
seeks to fill this gap in knowledge using genome-wide approaches that ultimately focus on key regulatory nodes.
During the last funding cycle, we provided compelling evidence that the commitment of T cell progenitors to the
αβ and γδ T cell fates depends on differences in T cell receptor (TCR) signal strength. These signaling
differences regulate fate by proportional induction of Id3, which causes graded repression of the function of E
box DNA binding proteins (E proteins). Using genome-wide approaches to define changes in E protein-DNA
binding, we generated a number of novel insights into the control of γδ T lineage specification, which can be
distilled into 3 themes: Theme 1) E protein specificity – E protein family members exhibit distinct responses to
the TCR signals of differing intensity/duration that specify fate and play distinct roles in supporting γδ T cell
development (Proj1/3/4); Theme 2) Non-coding transcription - E protein binding is extensively associated long
non-coding RNAs (lncRNA), such as ThymoD (all Projects), Importantly, Project 4 has developed novel imaging
approaches to study lncRNA function, by visualizing lncRNA promotion of chromosome looping in real time in
live cells; and Theme 3) Human γδ development - Project 3 developed a novel human pluripotent stem cell
(PSC) based system for studying human γδ T cell development, which revealed a requirement for HEB. In our
renewal application, we will explore these themes by integrating the complementary skills of the four project
leaders. The Zúñiga-Pflücker lab, together with Michele Anderson, will focus on the specific roles of E protein
family members, and their responsiveness to Id-mediated repression, in orchestrating lineage commitment in
mouse (theme 1) and human (theme 3) differentiation models. Their observations will inform the efforts of the
Murre lab to understand the molecular basis by which E protein family members control ThymoD expression, a
lncRNA (theme 2), which orchestrates both the onset of αβ lineage commitment and the ultimate loss of αβ fate
potential upon γδ lineage commitment. The efforts of both the Zúñiga-Pflücker and Murre labs will enable the
Wiest lab (with Dietmar Kappes) to understand the role of E protein family members and non-coding transcription
(theme 2) in specifying the IL-17 producing effector fate through E protein binding sites near the Tcf7 and Zbtb7b
loci. Finally, all Projects will inform efforts of Zhuang to understand how E protein family members (theme 1) and
non-coding transcription (theme 2) control the generation and function of the stereotyped γδ TCR complexes
that drive NKγδT cell development. All projects will continue to rely on the genomic expertise of Core B to assess
the implications of destroying E protein binding sites on the genomic architecture, and then link those changes
to cell fate. The collective efforts of these four projects promise to provide great insight into the role of E proteins
in controlling both γδ development and function, which is of critical importance to human health and disease.
项目总结/摘要
尽管越来越多的人认识到γδ T细胞在宿主防御和免疫病理学中发挥的关键作用,
控制其发育和效应子功能的分子事件仍然知之甚少。我们的节目
旨在填补这一知识空白,使用全基因组的方法,最终集中在关键的监管节点。
在上一个资助周期中,我们提供了令人信服的证据,证明T细胞祖细胞的承诺,
αβ和γδ T细胞命运取决于T细胞受体(TCR)信号强度的差异。这些信令
差异通过Id 3的比例诱导调节命运,这导致E
盒DNA结合蛋白(E蛋白)。使用全基因组方法来定义E蛋白-DNA的变化
结合,我们产生了一些新的见解控制γδ T谱系规范,这可以是
主题1)E蛋白特异性- E蛋白家族成员表现出不同的反应,
不同强度/持续时间的TCR信号指定命运并在支持γδ T细胞中发挥不同作用
发展(Proj 1/3/4);主题2)非编码转录- E蛋白结合广泛相关的长
非编码RNA(lncRNA),如ThymoD(所有项目),重要的是,项目4开发了新的成像技术,
研究lncRNA功能的方法,通过可视化lncRNA促进染色体成环的真实的时间,
活细胞;和主题3)人类γδ发育-项目3开发了一种新型人类多能干细胞
(PSC)该系统用于研究人γδ T细胞发育,揭示了HEB的需求。在我们
更新申请,我们将通过整合四个项目的互补技能来探索这些主题
领导人的人选信号Zúñiga-Pflücker实验室与Michele安德森一起将专注于E蛋白的特定作用
家庭成员,以及他们对ID介导的抑制的反应,在策划血统承诺中,
小鼠(主题1)和人(主题3)分化模型。他们的观察将有助于
Murre实验室了解E蛋白家族成员控制ThymoD表达的分子基础,
lncRNA(主题2),协调αβ谱系定型的开始和αβ命运的最终丧失
γδ谱系定型的潜力。Zúñiga-Pflücker和Murre实验室的努力将使
Wiest实验室(与Dietmar Kappes)了解E蛋白家族成员和非编码转录的作用
(主题2)通过Tcf 7和Zbtb 7 b附近的E蛋白结合位点确定IL-17产生效应子的命运
的位点最后,所有项目将告知庄的努力,以了解E蛋白家族成员(主题1)和
非编码转录(主题2)控制定型γδ TCR复合物的产生和功能
驱动NKγδT细胞发育。所有项目将继续依靠核心B的基因组专业知识来评估
破坏E蛋白结合位点对基因组结构的影响,然后将这些变化联系起来,
细胞的命运。这四个项目的共同努力有望为E蛋白的作用提供更深入的了解
控制γδ发育和功能,这对人类健康和疾病至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L. WIEST其他文献
DAVID L. WIEST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L. WIEST', 18)}}的其他基金
Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
- 批准号:
10024573 - 财政年份:2020
- 资助金额:
$ 214.45万 - 项目类别:
Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
- 批准号:
10462634 - 财政年份:2020
- 资助金额:
$ 214.45万 - 项目类别:
ThymUS 2020 International Conference on Lymphopoiesis
ThymUS 2020 国际淋巴细胞生成会议
- 批准号:
9913243 - 财政年份:2020
- 资助金额:
$ 214.45万 - 项目类别:
Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
- 批准号:
10256631 - 财政年份:2020
- 资助金额:
$ 214.45万 - 项目类别:
The ThymUS 2016 International Conference on Lymphopoiesis
ThymUS 2016 国际淋巴细胞生成会议
- 批准号:
8986580 - 财政年份:2016
- 资助金额:
$ 214.45万 - 项目类别:
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
核糖体蛋白旁系同源物对造血的调节
- 批准号:
8816656 - 财政年份:2015
- 资助金额:
$ 214.45万 - 项目类别:
Molecular Basis for gamma/delta T Lineage Specification
gamma/delta T 谱系规范的分子基础
- 批准号:
8608275 - 财政年份:2014
- 资助金额:
$ 214.45万 - 项目类别:
Regulation of Hematopoiesis By Ribosomal Protein Paralogs
核糖体蛋白旁系同源物对造血的调节
- 批准号:
8880580 - 财政年份:2014
- 资助金额:
$ 214.45万 - 项目类别:
Regulation of hematopoiesis by ribosomal protein paralogs
核糖体蛋白旁系同源物对造血的调节
- 批准号:
10548846 - 财政年份:2014
- 资助金额:
$ 214.45万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 214.45万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 214.45万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 214.45万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 214.45万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 214.45万 - 项目类别:
Standard Grant